Navigation Links
Chlamydia Antibody Panel, IgG & IgM by IFA

ProductsChlamydia Antibody Panel, IgG & IgM by IFA
Company ARUP Laboratories
Item Chlamydia Antibody Panel, IgG & IgM by IFA
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Chlamydia OIA
2. Clearview Chlamydia
3. Pathfinder® Chlamydia DFA
4. Pathfinder Chlamydia Microplate (EIA Microplate)
5. Pathfinder Chlamydia Culture Confirmation Test
6. MGB Alert Chlamydia pneumoniae ASR*
7. Chlamydia EIA
8. Chlamydia IgG
9. Chlamydia DFA Direct Specimen Collection Kit
10. Chlamydia DFA Direct Specimen Test
11. Chlamydia Antibody Panel, IgG by IFA
... InstaCheck® multi-drug test device provides ... easily. Negative results can be ... 3 minutes; positive results require ... one-time urine sample application will ...
... are available in 14 configurations including the ... Microgenics Antibody Technology, the SureStep™ MDMA (Ecstasy) ... immunoassay targeted to detect MDMA that has ... but no cross-reactivity to any isomer of ...
... At Home Drug Test is the first rapid ... home use. The kit includes a rapid drug-screening ... instructions, a handbook with frequently asked questions and ... to the laboratory if the screening device indicates ...
... Our most popular onsite test! QuickScreen™ ... the urine sample, and your choice of ... QuickScreen™ multi-panels offer total flexibility for your ... into the specimen and the built-in timer ...
Medicine Products:
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Onyx Pharmaceuticals, ... safety data from the pivotal Phase 2b 003-A1 ... carfilzomib is well-tolerated in heavily pre-treated relapsed and ... today at the ASH/ASCO Joint Symposium at the ... Hematology (ASH) in New Orleans. Enrollment in this ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
(Date:12/5/2009)... 5 There have been significant scientific advances in ... to gain a better understanding of how certain diseases ... provide patients with the best care. Research presented today ... of Hematology explores optimal induction therapies for managing multiple ...
(Date:12/5/2009)... myeloproliferative disorders are serious and often deadly blood ... Meeting of the American Society of Hematology introduces ... for patients suffering from acute promyelocytic leukemia, chronic ... that are based on a better understanding of ...
(Date:12/5/2009)... today announced the launch of International Solutions, an innovative new international ... its UK equivalent. In addition to offering customers the flexibility to ... needs and budgets, International Solutions enables customers to tailor their benefits ... , ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... positive results, ROSEMONT, Ill., Nov. 3 ... condition known as clubfoot,have similarly high levels of ... November 2008 issue of The Journal of Bone ... strategies use different,approaches, each brings positive outcomes for ...
... EL SEGUNDO, Calif., Nov. 3 The ... only national organization creating hope in a,comprehensive ... and,advocacy for a cure, launches Raise Your ... Pancreatic,Cancer Awareness Month. Raise Your Voice and ...
... The Zon hearing aid, designed by,Stuart Karten Design for ... presented by the Smithsonian,s Cooper-Hewitt, National Design,Museum., At ... New,York on Oct. 23, Padma Lakshmi, host of Bravo,s ... to Stuart Karten., "In developing Zon, we sought ...
... Group, the,premier strategic interactive marketing agency serving the ... Deloitte,s prestigious Fast,50 Program for Greater Philadelphia - ... and life sciences companies in the,area by Deloitte ... Rankings are based on the percentage revenue growth ...
... "When my father was formally,diagnosed with Alzheimer,s in ... article I could get my hands on," writes Michele ... (published by,AuthorHouse -- http://www.authorhouse.com ). "Educate, educate, educate ... that once I knew the facts, I,could get the ...
... trend, researchers say , , MONDAY, Nov. 3 (HealthDay ... United States is dramatically increasing as more kids ... hyperactivity disorder (ADHD), researchers report. , Increased prescribing ... obesity among children and the health consequences of ...
Other Medicine News:Health News:Non-Surgical Clubfoot Treatments Bring High Level of Success 2Health News:Non-Surgical Clubfoot Treatments Bring High Level of Success 3Health News:Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month 2Health News:Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month 3Health News:Stuart Karten Design's Zon Hearing Aid Wins 2008 Cooper-Hewitt People's Design Award 2Health News:Stuart Karten Design's Zon Hearing Aid Wins 2008 Cooper-Hewitt People's Design Award 3Health News:Cadient Group Ranked 34th in Deloitte's Fast 50 Program for Greater Philadelphia 2Health News:'A Conversation About Alzheimer's': Woman Shares Story of Love, Hope, Loss and Survival in New Book About Alzheimer's Disease 2Health News:Use of Kids' Meds on the Increase 2Health News:Use of Kids' Meds on the Increase 3
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC ... and Trademark Office has allowed its patent application on ... the manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... very high concentration of dendritic cells (which are the ...
(Date:12/4/2009)... N.J., Dec. 4 Depression, anxiety disorder, bipolar ... and migraine: These are among the comorbidities reported ... they had been diagnosed with epilepsy versus those ... of approximately 173,000 households across the U.S. ,, ...
(Date:12/3/2009)... ACTON, Mass., Dec. 3 Allen Medical Systems, a ... ), today announced the launch of its new Allen ... www.AllenAmatech.com . ,, The website reinforces the ... of the new product catalog, with detailed descriptions and ...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Evolvent Awarded Health Information Exchange Contract 13638 1Evolvent Awarded Health Information Exchange Contract 13638 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3LSTM to lead EU project to coordinate antimalarial drug research 54952 1LSTM to lead EU project to coordinate antimalarial drug research 54952 2